The law which introduces a tax on compensated drugs (the so-called “clawback” tax) was adopted on Monday, November 14, by the Romanian Senate, with amendments meant to ensure Romanian patients will still be able to accede to compensated drugs, a release by the Romanian Association of International Drug Manufacturers (ARPIM) informs. 87 pc of the senators voted in favour of adjusting the tax. Furthermore, the Senate ensured the tax was easier to apply and would guarantee solid revenue to boost the insufficient budget allotted to medicine. Thus, a minimum RON 600 M will be added to the healthcare budget in 2012 by setting a payment ceiling of 10 pc of the annual compensated drugs consumption, to be paid by the manufacturers. “We think it is essential that the clawback tax be implemented, as the healthcare budget needs at this time the amounts which can be collected from its application. However, this tax should be directly correlated to the patients’ needs for compensation, ensuring they can still accede to drugs,” Cristian Lutan, deputy executive director of ARPIM, stated.